Why the study?
Does intravenous streptokinase successfully treat acute prosthetic valve thrombosis in a primigravida during early pregnancy?
Does intravenous streptokinase successfully treat acute prosthetic valve thrombosis in a primigravida during early pregnancy?
Intravenous streptokinase was successfully used to treat acute prosthetic valve thrombosis in a primigravida during early pregnancy.
May be considered in rare cases; leaves open need for prospective safety data in pregnancy.
Regardless of the improvements in the design of prosthetic heart valves and the use of anticoagulation, systemic embolism and valve thrombosis remains the most dreaded complications of mechanical heart valve replacement. A course of thrombolytic therapy may be considered as a first-line therapy for prosthetic heart valve thrombosis. The safety of thrombolysis in early pregnancy is not known. We describe a primigravida with mitral valve replacement status presenting with acute prosthetic valve thrombosis and treated successfully with intravenous streptokinase.
No takes yet. Share an insight, caveat, or question.
Srinivas et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: